Objective: To assess the awareness of past medical history and long-term care issues of childhood cancer survivors (CCS) in Korea. Methods: A nationwide survey was conducted on CCS and their parents in 10 regional cancer centers in Korea. Answers regarding cancer diagnosis and treatment history were compared with the treatment summary and categorized into three ('specific,' 'general,' and 'no') or two ('yes' and 'no') groups. Results: Out of 343 contacts, 293 dyads completed the survey, and 281 dyads were analyzed. Awareness of cancer diagnosis was mostly specific for parents (76.5%) and CCS (35.2%). Awareness of anti-cancer treatment exposure was mostly general (84.6% for surgery, 67.9% for chemotherapy, and 53.9% for hematopoietic stem cell transplantation) rather than specific. In particular, more than half of the parents were not aware of the exposure to cardiotoxic agents (72.9%) or radiation therapy (56.3%). Providing information about long-term side effects and prevention of secondary cancer was significantly correlated only with more concern and more followup visits (P ≤ 0.001, respectively), without correlation with more specific awareness of exposure to cardiotoxic agents or radiation.
Introduction
Childhood cancer is a rare disease. About 1100 children (<1% of the total cancer incidence) are diagnosed with cancer every year in Korea. However, long-term care for childhood cancer survivors (CCS) is an important issue. The survival rate for CCS has increased from 56.2% (1993) (1994) (1995) to 78.2% (2007) (2008) (2009) (2010) (2011) , and there arẽ 25 000 CCS in Korea (1). They not only have a much longer life expectancy than adult cancer survivors, but they also grow up to be important members of the society.
In this regard, long-term care guidelines have been published for CCS. It has been shown that at least two-thirds of CCS have more than one late side effect, and one of every four of these side effects is serious (2, 3) . This is closely related with exposure to chemotherapy agents or to radiation, which requires early detection and management (4) . On the other hand, pediatric oncologists and physicians in general are not familiar with the proper care for adolescent CCS in terms of the importance of knowing the late side effects of cancer treatment (4) . Therefore, not only the physician's attention but also the patient's knowledge of their own medical history is necessary for achieving appropriate long-term care.
In Korea, researchers have reported that over 50% of cancer survivors suffer from late side effects and they have indicated the need for early and well-timed intervention (5-7). Nevertheless, both in Korea as well as in other countries of Asia, there are no representative nationwide reports on the awareness of CCS regarding their own medical history, which is necessary for long-term care.
Therefore, this study aimed to assess the accuracy of knowledge about past medical history and attitude towards long-term care issues among parents of CCS in Korea.
Materials and methods

Nationwide survey
We performed the first nationwide survey to understand the needs of CCS and their parents in Korea. The National Cancer Center and nine regional cancer centers in each Korean province participated in the survey. Survey participants were recruited at outpatient clinics of each institution from January 2011 to February 2012. CCS and their parents answered questionnaires through person-to-person interviews conducted by trained interviewers, and health care professionals completed their medical record review forms.
Study subjects
Subjects were included if their child (1) was diagnosed with cancer via pathology according to the International Code of Disease for Oncology, 3rd Edition (ICD-O-3), (2) was diagnosed under the age of 20, (3) underwent anti-cancer treatment and (4) has been followed up for more than 2 years after treatment.
Subjects were excluded if they (1) were under the age of 10 at the time of the survey, (2) had a history of significant psychological disease (psychosis) or were taking antipsychotics and (3) had multiple primary cancers.
Survey questionnaire
The most important part of the survey was the section regarding awareness of past medical history and follow-up care. Parents were asked extensive questions about sociodemographic characteristics, awareness of past cancer diagnosis, and the type of treatment that their child received. They were also asked if they were provided with information about the past diagnosis and treatment, long-term side effects of treatment, and prevention of secondary cancers (Appendix 1). CCS were asked whether they knew their cancer diagnosis or not and, if they knew, what the category of diagnosis was (Appendix 2). Health care professionals were asked to complete each patient's medical summary including cancer diagnosis, date of birth, date of cancer diagnosis, treatment received and date of completion of cancer treatment.
Classification of awareness of past diagnosis and treatment
Based on their medical record review as the standard, answers of parents and CCSs were classified into three (specific, general and no awareness for diagnosis, surgery and chemotherapy) or two (yes or no awareness for the use of cardiotoxic agents and radiation therapy) categories of operational definition. In the former case, 'specific' awareness indicated that the answer matched with the medical record review in terms of both the general category and specific diagnosis or treatment. 'General' awareness indicated that the answer matched with the medical summary only in terms of the general category of diagnosis or treatment. 'No' awareness means that the answer did not match with the summary. For the awareness of diagnosis, correct answers for Wilms tumor, neuroblastoma and retinoblastoma in the questionnaire were regarded as 'specific' knowledge per se. CCSs' answers to their diagnosis were classified according to the same criteria as parents. For the awareness of chemotherapy, correct answers on the use of cardiotoxic agents were regarded as 'specific' because they are the most important anti-cancer agents that can bring about fatal latent effects, and require regular long-term follow-up. In the latter case, answers on awareness of exposure to cardiotoxic chemotherapy agents or radiation therapy were classified into 'yes' or 'no' categories because we did not ask about the specific name of agents or the specific site of therapy.
Two researchers, a pediatric oncologist and a family physician, independently classified the category of answers by comparing them to medical record reviews. After primitive coding, the two researchers reviewed cases of discordance and recoded them into either a specific category or unclassifiable missing value by consensus.
Statistical analysis
Descriptive data about respondents' characteristics, perceived risk, perceived need for diagnostic tests and agreement with a positive diagnosis are presented as frequency and proportion. In descriptive statistics, we compared characteristics between the two groups using t tests for continuous variables and chi-square test or Fisher's exact test as appropriate for categorical variables. To search for factors affecting awareness among childhood cancer survivors, an ordinary variable, we adopted the ordinary logistic regression model. The final ordinary logistic regression model was derived from results of univariate anlaysis and stepwise regression analysis. We used STATA version 12.0 (STATA Corp., Houston, TX) to analyze the data, with statistical significance defined as P ≤ 0.05.
Results
Characteristics
Out of 343 contacts, 293 dyads completed the survey, yielding a response rate of 85.4%. A total of 281 dyads were included in the final analysis excluding one involving a case of aplastic anemia, two involving unidentifiable diagnoses, two cases where participants responded within the limit of 2 years after end of treatment, and seven wherein responses were obtained from caregivers other than the parents.
Most of the respondents were the mothers of the children, with mean age of 43.25 years. More than half of the respondents were educated more than high school (58.4%) and lived in small cities (54.5%). The majority of respondents were married (87.5%) and insured by Medicare (86.5%) -a universal health care system based on mandatory social insurance covering nearly all Koreans except the lowest 3% income bracket -at the time of the survey. Children were most frequently diagnosed with leukemia (42.4%) at <10 years of age (73.7%), for which they received chemotherapy (95.4%). After a median follow-up of 5.13 years, they were now older than 13 years (67.6%) ( Table 1) .
Awareness among parents
Most of the parents were aware of the exact past diagnosis (specific, 76.5%; general, 17.4%). However, awareness of anti-cancer treatment exposure was mostly general rather than specific. Parents were aware of surgery (specific, 6.7%; general, 84.6%), chemotherapy (specific, 23.1%; general, 67.9%), and hematopoietic stem cell transplantation (specific, 46.2%; general, 53.9%). In particular, most parents were not aware that their child was exposed to cardiotoxic agents (72.9% of 181 dyads) or radiation therapy (56.3%; 80 dyads). For the awareness of exposure to cardiotoxic agents which used yes/no question, answers of parents and information obtained from medical record reviews showed κ coefficient of 0.146, which means very low level of agreement. Low awareness of exposure to cardiotoxic agents and radiation therapy was observed mainly among parents of leukemia and lymphoma patients ( Table 2) .
Awareness among childhood cancer survivors and related factors
Most CCS were aware of their past diagnosis (specific, 35.2%; general, 29.2%). However, 35.6% of them were not aware. In univariate analysis, CCSs' Odds Ratios (ORs) of not being aware of their diagnosis showed significantly positive correlations with that of their parents' awareness and time since the end of treatment. Older Other solid tumor includes cases of Wilms tumor (n = 14), neuroblastoma (n = 13), retinoblastoma (n = 6), soft tissue sarcoma (n = 21), malignant bone tumor (n = 9), liver cancer (n = 7) and miscellaneous tumors (n = 37).
age of CCSs at the time of survey and diagnosis showed negative correlation with not being aware of their diagnosis. In multivariate analysis using ordinary logistic regression model, correlations with the awareness of parents (aOR, 4.96; 95% CI, 1.54-15.94 for not being aware of diagnosis), age at the time of survey (aOR, 0.44; 95% CI, 0,0.26-0.75 for more than 13 years old) and age at diagnosis (aOR, 0.40; 95% CI, 0.20-0.81 and aOR, 0.29; 95% CI, 0.13-0.63 for CCSs diagnosed at the age from 10 to 12 years and at the age of over 13, respectively) were observed (Table 3) .
Information provided
Less than half of the participants answered that they were provided with a medical summary about past diagnosis and treatment (46.6%). However, this was not significantly correlated with more awareness among parents regarding cardiotoxic agents or radiation therapy exposure, which are representative risk factors of long-term side effects and secondary cancer (Table 4) . Parents were also asked whether information was provided about the risk of long-term side effects (50.9%) and prevention of secondary cancer (37.4%). On the other hand, having received this information showed rather a significant correlation with more concerns regarding treatment-related problems and more follow-up visits for risk of side effects, without any correlation with the awareness of these risk factors (Table 4) .
Discussion
To our knowledge, this is the first Asian report concerning the awareness of CCS and their parents about cancer treatment history related with the risk factors and long-term health care issues. There was a multi-institutional research about overlapping issues in Japan, on transition of care of CCSs. However, they focused on patterns of medical visits, especially to previous cancer treatment hospitals. They did not deal with awareness of patients about their diagnosis and treatment history and its influence on medical visits, although they investigated the clinical history of their participants through medical record reviews as possible influential factors (8) .
According to our observation, parents' awareness about the past cancer diagnosis of their children was similar to that observed in western countries (9) . Their awareness about past cancer diagnosis was also significantly correlated with that of their children (CCS).
However, they showed a notable lack of awareness about specific treatment history such as cardiotoxic agent exposure and radiation therapy, which are life-long risk factors of long-term side effects and secondary cancer. Low awareness of exposure to cardiotoxic agents and radiation therapy might be partly explained by the complexity of chemotherapy regimens and nonspecific irradiation ranges such as in whole body radiation in leukemia and lymphoma.
Meanwhile, a notable finding was that provision of specific information showed no correlation with better awareness of the above mentioned risk factors. On the other hand, provision of specific information showed a significant correlation with higher concerns about future health problems and increased follow-up visits. This finding is similar to that in some recent reports: risk-based education increased the awareness surrounding personal health risks, and an automatically generated cancer survivorship care plan did not improve patient reported outcomes but only increased the concern and frequency of visiting physicians (10, 11) . Our point is not Correct answer for Wilms tumor, neuroblastoma and retinoblastoma was classified into specific awareness without questions about more specific diagnoses. N, number; OR, odds ratio for not being aware of the diagnosis; aOR, adjusted odds ratio for not being aware of the diagnosis; SD, standard deviation.
a Correspondence of the answer to the medical summary for the specific (both general category and specific question), general (general category only), or no (does not match at all) awareness groups. Odds ratio adjusted by age at survey, age at diagnosis, and parents' awareness of diagnosis. The larger the OR and aOR, the more likely CCSs are not aware of their diagnosis. denying the necessity of providing medical summaries to patients. This necessity cannot be questioned. Rather, our point is that parents and CCSs could not accept and use information they were provided with by themselves. What these findings suggest would be that, in addition to providing medical summaries, we need to make an effort to find out easily acceptable forms and ways of providing them. It may include investigating the proper context to deliver and use the information concerned, such as in patient follow-up and transition of care. Our findings should be interpreted in the context of some limitations. First, we have to consider possible selection bias caused by recruiting participants through ten cancer centers nationwide, where most of them were tertiary hospitals. These participants might be more active or have less restriction in follow-up, and these tendencies might lead us to overestimate the awareness, as in healthy worker bias. Second, there were only adolescent survivors and no adult survivors because they were recruited at pediatric clinics. This limited the possibility of better awareness among CCS and the quantity and quality of inquiry we could ensure. Third, we classified answers of parents and CCSs using operational definitions with three (none, specific and general) or two categories (yes or no). It was an inevitable choice to present several phenomena observed in CCSs, who comprise a very small population in Korea. Nonetheless, we should keep in mind the heterogeneity of diseases and types of treatment. Fourth, questions about providing a medical summary were asked only to parents rather than health care professionals, which would imply the possibility of recall bias, mainly through underestimation of the provision of the written summary. Fifth, the question about provision of medical summaries was not followed by detailed questions about the items, method of provision, understanding of or satisfaction with the information.
Conclusion
In spite of these limitations, our findings suggest that more effort to improve awareness about the risk factors of long-term side effects or secondary cancer in CCS is necessary. In addition to providing the information itself, the manner of providing the information needs to be improved, and an appropriate patient referral system within which we can use it needs to be established.
If you know of the past cancer diagnosis of your child, check the correct category and specific diagnosis. 
